B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PI4KA

MOLECULAR TARGET

phosphatidylinositol 4-kinase alpha

UniProt: P42356NCBI Gene: 52971 compounds

PI4KA (phosphatidylinositol 4-kinase alpha) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PI4KA

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Wortmannin1.102

About PI4KA as a Drug Target

PI4KA (phosphatidylinositol 4-kinase alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented PI4KA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PI4KA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.